Priscilla Ponte, NP
Nurse Practitioner · East Providence, RINPI 1376227009
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 42.9% of the total. Reporting peaked in 2024 at $4,359 and has fallen 88.5% since, to $500 in 2025. Among nurse practitioner clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $57.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- AbbVie$356
- Lilly USA, LLC$105
- Bristol Myers Squibb$103
- Nevro Corp.$93
- plus $404 from 10 others
What the payments were for
- Travel & lodging$2,61651%
- Food & beverage$2,48648%
- Education$541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $2,212 |
| Boston Scientific | 16 | $1,885 |
| AbbVie | 14 | $356 |
| Lilly USA, LLC | 6 | $105 |
| Bristol Myers Squibb | 4 | $103 |
| Nevro Corp. | 1 | $93 |
| AstraZeneca | 4 | $85 |
| Valinor Pharma, LLC | 3 | $60 |
| CSL Behring | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Curonix LLC | 2 | $37 |
| Globus Medical | 2 | $32 |
| UCB, Inc. | 1 | $26 |
| Argenx US, Inc. | 1 | $24 |
| Pfizer | 1 | $15 |
| Catalyst Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,511
- SYNCHROMEDII$1,238
- GENERAL PAIN MANAGEMENT$127
How this compares
$5,157 in reported general payments places this provider in the 95th percentile of 396 nurse practitioner providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 46 | $28,357 |
| Xtampza ErOxycodone Myristate | 13 | $11,183 |
| Buprenorphine | 39 | $8,291 |
| Oxycodone Hcl | 278 | $4,230 |
| Lidocaine | 52 | $4,029 |
| Gabapentin | 188 | $3,217 |
| Morphine Sulfate ErMorphine Sulfate | 140 | $3,179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 158 | $2,673 |
| Pregabalin | 126 | $2,614 |
| Tizanidine Hcl | 95 | $2,476 |
| Diclofenac Sodium | 65 | $2,457 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 130 | $2,425 |
| Naloxone Hcl | 36 | $2,264 |
| Celecoxib | 59 | $2,016 |
| Baclofen | 71 | $1,668 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in East Providence
- Linda YoungLincoln$19K
- Lynne GlaserCumberland$17K
- Stephanie CostaWarwick$9K
- Maria SilvaJohnston$7K
- Natalie DriscollMiddletown$6K
- Lea KellyProvidence$5K
- Kathleen ParkerWarwick$5K
- Jennifer JohnsonNarragansett$5K
- Heather GlennWarwick$4K
- Susan BordonaroMiddletown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.